CR
ClinTrial Research, Inc.
SEC filingOther Technology · Holly Springs, NC
Amount raised$5Msold at filing
Total offering$5M$5K still open
Investors in the raise1count reported to the SEC
FiledJan 5, 2026first sale Nov 26, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jay Scott SantoroDirector
Wendy Scott TomlinsonExecutive Officer
Rishi Scott ReddyDirector
Jennifer Laughlin YevoliExecutive Officer, Director
Subhash Scott GumberDirector
Andrew Scott RittsDirector
Douglas Scott StrasnickExecutive Officer
Sam Scott SearcyExecutive Officer, Director
Ron Scott CreatoreExecutive Officer
Gautam Scott PatelDirector
Executive officers, directors and promoters as listed on the Form D.